Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
Erythema multiforme in its most extreme form has traditionally been divided between toxic epidermal necrolysis and Stevens-Johnson Syndrome. These two life-threatening skin diseases are now considered part of the same spectrum of disease. They can be differentiated by clinical and histological criteria. We can also now predict which patients are apt to have the most guarded prognosis. Treatment by multiple agents is imperfect, but offers a better chance of a good outcome than ever before.
KeywordsImmune memory Histocompatibility complex Apoptosis “Target” lesions “Wet paper” appearance Asboe-Hanson sign IVIG Plasmapheresis
- Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. Philadelphia: Mosby Elsevier; 2008.Google Scholar
- Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol. 1990;126(1):43–7.CrossRefPubMedGoogle Scholar
- Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D, Wolff K. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012.Google Scholar
- Ngan V, Oakley A, Dyall-Smith D. Stevens Johnson syndrome & toxic epidermal necrolysis. 2009. http://dermnetnz.org/reactions/sjs-ten.html. Accessed 5 May 2014.
- Rzany B, Mockenhaupt M, Baur S, Schroder W, Stocker U, Mueller J, et al. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. J Clin Epidemiol. 1996;49(7):769–73.CrossRefPubMedGoogle Scholar
- Schneck J, Fagot J-P, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol. 2008;58(1):33–40.CrossRefPubMedGoogle Scholar